{"log_id": 1877353028907959487, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.031652, "average": 0.88489, "min": 0.492599}, "location": {"width": 207, "top": 86, "height": 33, "left": 877}, "words": "说明书第3/"}, {"probability": {"variance": 0.013783, "average": 0.832058, "min": 0.623983}, "location": {"width": 92, "top": 116, "height": 24, "left": 170}, "words": "816534.3"}, {"probability": {"variance": 0.007012, "average": 0.969305, "min": 0.65526}, "location": {"width": 869, "top": 152, "height": 67, "left": 161}, "words": "少的产量( Glover和 Hames(主编),1995,表达系统,IRL出版社,牛津"}, {"probability": {"variance": 0.006506, "average": 0.977174, "min": 0.57465}, "location": {"width": 882, "top": 197, "height": 67, "left": 162}, "words": "纽约一东京)、因此这种类型的蛋白通常不适于医药诊断和治疗意义上的变"}, {"probability": {"variance": 0.000363, "average": 0.990002, "min": 0.951893}, "location": {"width": 141, "top": 271, "height": 38, "left": 162}, "words": "态反应用途"}, {"probability": {"variance": 1.5e-05, "average": 0.998334, "min": 0.979923}, "location": {"width": 815, "top": 290, "height": 64, "left": 230}, "words": "本发明所述方法的具天然构象的产物可优选用于过敏症(尤其是昆虫"}, {"probability": {"variance": 0.000134, "average": 0.996002, "min": 0.933307}, "location": {"width": 878, "top": 336, "height": 66, "left": 167}, "words": "叮咬过敏)的胞外和胞内诊断。该与天然一致的折叠形式可以以已建立的"}, {"probability": {"variance": 0.010601, "average": 0.951977, "min": 0.641228}, "location": {"width": 308, "top": 406, "height": 42, "left": 163}, "words": "方法用于IgE抗体的检测"}, {"probability": {"variance": 0.000394, "average": 0.995577, "min": 0.888768}, "location": {"width": 819, "top": 430, "height": 63, "left": 231}, "words": "另一方面,本发明所产生的突变体(其特点为根本没有或仅部分具有"}, {"probability": {"variance": 0.005623, "average": 0.980678, "min": 0.582598}, "location": {"width": 888, "top": 474, "height": 66, "left": 164}, "words": "1gE反应活性的构象)可在特异性免疫治疗制剂中作为低变应原组分来进"}, {"probability": {"variance": 1.1e-05, "average": 0.997981, "min": 0.986958}, "location": {"width": 890, "top": 521, "height": 63, "left": 163}, "words": "行使用。按本发明,上、下文中所用的术语“低变应原的”是指,由于减"}, {"probability": {"variance": 0.001014, "average": 0.990713, "min": 0.839726}, "location": {"width": 891, "top": 565, "height": 65, "left": 164}, "words": "弱的IgE反应所引起的减弱至没有,优选从5%到95%,尤其是从20%到"}, {"probability": {"variance": 5e-06, "average": 0.998577, "min": 0.99286}, "location": {"width": 528, "top": 624, "height": 51, "left": 166}, "words": "85%的减弱过敏原性(与天然过敏原相比)"}, {"probability": {"variance": 0.000195, "average": 0.994415, "min": 0.93649}, "location": {"width": 827, "top": 656, "height": 65, "left": 231}, "words": "本发明是一种方法,用此方法可在细菌(大肠杆菌)中产生重组过敏"}, {"probability": {"variance": 4e-06, "average": 0.9991, "min": 0.990764}, "location": {"width": 892, "top": 702, "height": 65, "left": 167}, "words": "原。第一个纯化步骤是对不溶性蛋白聚集物进行相当可观的富集。然后在"}, {"probability": {"variance": 8e-06, "average": 0.998758, "min": 0.988647}, "location": {"width": 892, "top": 747, "height": 63, "left": 168}, "words": "不添加还原剂的情况下对这些聚集物进行变性。根据接下来的透析条件的"}, {"probability": {"variance": 0.000198, "average": 0.995588, "min": 0.921766}, "location": {"width": 893, "top": 790, "height": 65, "left": 168}, "words": "不同,可以得到不同的折叠形式。至关重要的一点是,这些分子是单体的"}, {"probability": {"variance": 0.015066, "average": 0.938009, "min": 0.566026}, "location": {"width": 895, "top": 833, "height": 69, "left": 170}, "words": "且是可溶的。第一个可溶的折叠突变体具有秀经过数原相比的IgE反"}, {"probability": {"variance": 0.002494, "average": 0.979492, "min": 0.748657}, "location": {"width": 898, "top": 871, "height": 81, "left": 168}, "words": "应活性并可因此用于诊断目的。各种类型可通过用全半胱氨酸的溶"}, {"probability": {"variance": 0, "average": 0.999676, "min": 0.998346}, "location": {"width": 203, "top": 950, "height": 37, "left": 167}, "words": "液进行透析得到"}, {"probability": {"variance": 0.008357, "average": 0.964266, "min": 0.618628}, "location": {"width": 831, "top": 962, "height": 75, "left": 237}, "words": "另一个替代的可溶性折叠突变体在结椅与天然过敬不同,并且可"}, {"probability": {"variance": 0.009141, "average": 0.9725, "min": 0.481551}, "location": {"width": 900, "top": 1009, "height": 73, "left": 171}, "words": "由IgE反应活性的减弱或缺乏来加以区别。,这种类型的突变体适于"}, {"probability": {"variance": 0.015806, "average": 0.960338, "min": 0.409192}, "location": {"width": 900, "top": 1058, "height": 64, "left": 171}, "words": "推动改良的免疫治疗。按本发明所述,用酸性缓冲(优选pH在3.5和"}, {"probability": {"variance": 0.000157, "average": 0.996243, "min": 0.926302}, "location": {"width": 885, "top": 1104, "height": 61, "left": 173}, "words": "6.5之间,具体在4.0和5.5之间)透析可得到这种类型的低变应原产品"}, {"probability": {"variance": 0.002185, "average": 0.987513, "min": 0.739617}, "location": {"width": 836, "top": 1147, "height": 62, "left": 240}, "words": "因此本发明也涉及具有减弱的IgE反应活性或过敏原性特征的重组"}, {"probability": {"variance": 3.4e-05, "average": 0.997855, "min": 0.97261}, "location": {"width": 906, "top": 1191, "height": 65, "left": 174}, "words": "昆虫过敏原。按本发明所述,与天然过敏原相比这些蛋白的过敏原性可减"}, {"probability": {"variance": 1.4e-05, "average": 0.9943, "min": 0.988866}, "location": {"width": 92, "top": 1269, "height": 28, "left": 175}, "words": "少95%"}, {"probability": {"variance": 0.005118, "average": 0.98469, "min": 0.600218}, "location": {"width": 838, "top": 1283, "height": 62, "left": 243}, "words": "具体来说,本发明涉及相应的重组黄蜂昆虫过敏原,尤其是来自常见"}, {"probability": {"variance": 0.004397, "average": 0.964496, "min": 0.768134}, "location": {"width": 914, "top": 1326, "height": 66, "left": 173}, "words": "黄胡蜂( yespula vulgaris)和德国黄蜂( Vespula germanica)的重组黄"}, {"probability": {"variance": 0, "average": 0.999822, "min": 0.999653}, "location": {"width": 175, "top": 1401, "height": 33, "left": 174}, "words": "蜂昆虫过敏原"}, {"probability": {"variance": 0.00366, "average": 0.983849, "min": 0.705899}, "location": {"width": 843, "top": 1418, "height": 65, "left": 244}, "words": "本发明涉及分离基本上纯的重组昆虫毒性过敏原的方法,其特征为该"}], "language": 3}